
Mark Cuban says AI will not replace radiologists due to model drift, inference costs, and liability—but will automate healthcare administrators' paperwork tasks.
The three largest pharmacy benefit managers are already deploying AI to cut claims processing and prior authorization times, testing whether such automation expands or compresses their margins.
What happened
Mark Cuban argued on X that radiologists will not be replaced by AI because foundation models become outdated upon release, inference at clinical scale costs far more than radiologist salaries, and combining AI with medical domain knowledge is complex. He separately claimed AI will replace most doctors' administrative tasks—the paperwork introduced by large healthcare conglomerates—rather than clinical judgment.
Why it matters
Cuban co-founded Mark Cuban Cost Plus Drug Company, which bypasses the pharmacy benefit manager (PBM) layer, so his framing reflects a specific business interest. However, the three largest PBMs—CVS Health (owner of Caremark), Cigna (owner of Express Scripts), and UnitedHealth Group (owner of Optum Rx)—are already deploying AI to automate the exact administrative work Cuban targets, raising the question of whether such automation will compress their operating margins or expand them.
What to watch
CVS reported Q2 2026 Health Services revenue of nearly $52 billion and launched an AI-enabled claims-assist manager that will reduce processing time by over 20%; Cigna reported Q2 2026 Evernorth revenue of $61.5 billion and said its Pharmacy Forward program cuts time to therapy in half and reduces clinician documentation time by up to 50%; UnitedHealth Group reported Q2 revenue of $112 billion and targets processing 80% of prior authorizations in real time by end of 2027.
Ask the AI about this article →
Cuban's argument inverts the conventional AI-disruption narrative in healthcare. Rather than focusing on whether machines can perform clinical tasks better than humans, he frames the question as one of cost, liability, and complexity. Foundation model drift—the degradation of model accuracy over time without retraining—combined with the per-query inference costs at clinical scale, creates an economic headwind for any radiology-replacement scenario. Adding domain knowledge (the ability to integrate AI findings into broader clinical workflows and liability frameworks) compounds the challenge further. Medicine, in his framing, is a business problem first and a capability problem second.
The administrative layer Cuban identifies is already under pressure from the three dominant pharmacy benefit managers. CVS Health, Cigna, and UnitedHealth Group all operate integrated PBM businesses that sit between manufacturers, insurers, pharmacies, and patients—a position that generates significant revenue but also significant administrative overhead. Their recent AI deployments target exactly the paperwork, claims processing, and prior authorization tasks that consume clinician and administrative labor. CVS's claims-assist manager, Cigna's Pharmacy Forward program, and UnitedHealth's real-time prior authorization push all suggest the incumbents recognize automation as both an opportunity and a competitive necessity.
Cuban's stake in this debate is transparent: he founded Mark Cuban Cost Plus Drug Company to bypass the PBM layer with transparent pricing, so his argument that the PBM administrative layer should be eliminated—or at least automated into smaller margins—reflects his business model directly. The open question for investors is whether the PBM conglomerates' AI investments will compress their operating leverage (margin erosion as automation reduces headcount-heavy administrative work) or sustain it (efficiency gains that protect revenue while cutting costs). The answer depends on whether the automation reduces the volume of work or simply reshapes its structure without reducing the layer's overall economic importance.
For example, today's edition would include:
AI-summarized, only the topics you pick — one digest a day via Email, Slack, or Discord.
Free · takes 30 seconds · unsubscribe anytimeWhat is AIToday? →
Ask AI anything about this article. Q&As are published on this page for other readers too.
A UK study by UK AI Security Institute and Limbic AI surveyed 6,474 British adults

Broadcom's Clayton Donley says companies are doing mission-critical work with AI agents quickly, but without t…
Bank of England governor Andrew Bailey warned that advanced AI poses risks to financial infrastructure in a le…
As AI agents perform real business tasks, 'Agentic Identity' (giving each AI a unique employee-like ID) and 'D…

Andrew Bailey, head of the world's financial stability watchdog, warned in a letter to G20 finance ministers a…

BHP, the world's largest mining company by market capitalization, has deployed AI across its operations
